Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics. Here, we have used 1062 EA patients with two years of follow-up to explore the value of anti-carbamylated protein (anti-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Regueiro, Cristina, Nuño, Laura, Ortiz, Ana M., Peiteado, Diana, Villalba, Alejandro, Pascual-Salcedo, Dora, Martínez-Feito, Ana, González-Alvaro, Isidoro, Balsa, Alejandro, González, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607236/
https://www.ncbi.nlm.nih.gov/pubmed/28931886
http://dx.doi.org/10.1038/s41598-017-09657-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607236/
https://www.ncbi.nlm.nih.gov/pubmed/28931886
http://dx.doi.org/10.1038/s41598-017-09657-5

Ejemplares similares